The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The restrictions began because the FDA declared a shortage of tirzepatide, often ...

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs ...

Looking for Zepbound (tirzepatide) online? Our expert team vetted the best places to buy this prescription-only weight loss medication. Plus, learn more about shortages, effectiveness, and online ...

Shares of Hims & Hers Health (HIMS) rallied on Tuesday after the telehealth company said it would begin selling branded versions of Eli ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

This integration evolves Noom’s comprehensive approach to weight management by enabling a streamlined solution for members ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Some people have experienced insomnia (difficulty sleeping) after starting Zepbound (tirzepatide). Sleep problems may be due to factors other than the drug itself since Zepbound is more likely to ...

Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration's ban on the practice and luring people away from ...